![]() |
市場調查報告書
商品編碼
1843564
2025年全球醫療設備人工智慧市場報告AI In Medical Devices Global Market Report 2025 |
||||||
近年來,人工智慧在醫療設備領域的市場規模迅速擴張,從2024年的100.8億美元成長到2025年的123.8億美元,複合年成長率達22.8%。這一成長主要歸功於早期機器學習演算法的出現、巨量資料分析的興起、精準醫療需求的不斷成長、監管部門的支持和核准,以及放射學領域的早期應用。
預計未來幾年,人工智慧在醫療設備領域的市場規模將呈指數級成長,到2029年將達到342億美元,複合年成長率(CAGR)為28.9%。預測期內的成長可歸因於以患者為中心的醫療模式、醫療保健支出的增加、監管支援和標準的提升、臨床決策支援的增強以及人工智慧在疾病預測和預防方面的應用。預測期內的關鍵趨勢包括增強放射學和影像學、人工智慧賦能的病理診斷、基因組學與人工智慧的融合、醫療保健領域的預測分析以及自然語言處理(NLP)。
其目標是透過整合先進的演算法、機器學習技術和其他人工智慧(AI)技術,提升醫療設備的效能和功能。將人工智慧應用於醫療設備將有助於提高診斷準確性、輔助外科手術、預測患者預後以及製定個人化治療方案。
人工智慧在醫療設備中的部署方式主要有兩種:雲端部署和本地部署。雲端部署利用網際網路上的遠端伺服器網路來儲存、處理和管理數據,而不是依賴本機伺服器或個人電腦。這種方法涵蓋多種技術,包括情境感知、深度學習、機器學習、自然語言處理和預測分析。這些技術應用於許多領域,包括患者治療、診斷和監測。人工智慧在醫療設備中的主要最終用戶包括醫院和醫療服務提供者、患者、製藥和生物技術公司以及醫療保險機構。
美國在2025年春季突然提高關稅及其引發的貿易摩擦,對資訊科技產業,特別是硬體製造、資料基礎設施和軟體部署領域,產生了重大影響。進口半導體、電路基板和網路設備的關稅上漲,推高了高科技公司、雲端服務供應商和資料中心的生產和營運成本。在全球範圍內採購筆記型電腦、伺服器和消費電子產品零件的公司,面臨更長的前置作業時間和價格壓力。同時,對專用軟體徵收的關稅以及主要國際市場的報復性措施,擾亂了全球IT供應鏈,並降低了海外對美國製造技術的需求。為了應對這些挑戰,該產業正在加大對國內晶片生產的投資,擴大供應商網路,並利用人工智慧驅動的自動化技術來增強韌性,更有效地控制成本。
本研究報告是商業研究公司(The Business Research Company)最新系列報告的一部分,該系列報告提供醫療設備人工智慧(AI)市場統計數據,包括全球市場規模、區域佔有率、醫療設備醫療設備醫療設備人工智慧市場細分、市場趨勢和商業機會,為您提供在醫療設備人工智慧行業取得成功所需的數據。這份醫療設備人工智慧市場研究報告對該行業的現狀和未來發展趨勢進行了詳細分析,為您提供所需的一切觀點。
未來五年28.9%的預測成長率較我們先前對該市場的預測略微下降了0.6%。這一下降主要歸因於美國與其他國家之間的關稅影響。對美國,直接影響可能源自於對依賴瑞士和德國精密零件的人工智慧手術機器人徵收的關稅增加,這將減緩醫療保健領域的進步。此外,由於相互關稅措施以及貿易緊張局勢和限制措施升級對全球經濟和貿易造成的負面影響,其影響範圍也將更加廣泛。
個人化醫療需求的不斷成長預計將推動人工智慧在醫療設備市場的發展。個人化醫療是一種量身定做的醫療保健方法,它充分考慮患者的個別特徵,例如遺傳、環境和生活方式,以提高治療效果和預後。基因組學的進步、病人自主權的增強以及治療效果的改善等諸多因素共同促成了個人化醫療需求的成長。透過處理大量的患者數據,包括基因資訊、病歷和生活習慣,人工智慧可以全面了解個體的特徵,並幫助制定個人化的治療方案。例如,總部位於美國的非營利組織「個人化醫療聯盟」(Personalized Medicine Coalition)在2024年2月報告稱,針對罕見疾病患者的新核准個人化治療藥物數量從2022年的6種增加到2023年的16種。因此,對個人化醫療日益成長的需求是推動人工智慧在醫療設備市場發展的重要動力。
預計未來幾年,醫療保健支出的成長將推動人工智慧在醫療設備市場的發展。醫療保健支出涵蓋所有用於提供醫療服務及相關活動的資源,包括資金和非資金。這部分支出對於人工智慧醫療設備的普及和應用至關重要,因為它使醫療服務提供者能夠投資於先進技術,從而改善患者照護和治療效果。例如,總部位於加拿大的非營利組織加拿大健康資訊研究所(Canadian Institute for Health Information)在2023年11月發布的報告顯示,預計2023年醫療保健總支出將達到3,440億美元,比前一年成長2.8%。因此,醫療保健支出的成長是推動人工智慧在醫療設備市場發展的關鍵因素。
醫療設備人工智慧市場正經歷由技術進步驅動的重大趨勢,領先企業積極採用新技術以維持其市場地位。 2022年3月,美國電腦硬體製造商英偉達公司發布了Clara Holoscan MGX平台,該平台專為醫療設備業設計,用於在邊緣開發和部署即時人工智慧應用。這項創新平台有助於打造具備先進人工智慧功能的醫療設備,包括影像和訊號處理、自然語言處理和預測分析。此外,它還整合了先進的安全功能並符合醫療保健行業法規,以確保患者資料的安全性和隱私性,從而實現醫療資料的即時處理,並為臨床決策提供有價值的資訊。
醫療設備人工智慧市場的主要企業正致力於建立策略聯盟,以加速人工智慧在醫療保健系統中的發展並獲得競爭優勢。這些聯盟旨在利用人工智慧增強藥物發現、設計和開發,並利用機器學習提高醫療設備製造效率並降低風險。 2023年3月,總部位於愛爾蘭的醫療設備公司Medtronic)與總部位於美國的軟體公司英偉達(NVIDIA)合作,共同建構一個用於醫療設備的人工智慧平台。此次合作將把英偉達的醫療保健和邊緣人工智慧技術整合到MedtronicGI Genius智慧內視鏡模組中,這是首個獲得FDA核准的人工智慧輔助大腸鏡檢查工具。這項策略夥伴關係旨在加速人工智慧在醫療保健系統中的應用,並為患者照護引入新的人工智慧解決方案。
2023年2月,總部位於美國的醫療技術和診斷公司GE醫療科技以30億美元完成了對Caption Health Inc.的收購。此次收購旨在擴大Caption Health Inc.開發的Caption AI的應用範圍,使其從循環系統領域擴展到包括初級保健、急診醫學和婦產科在內的多個醫療專科。 Caption Health以其在人工智慧醫療產品製造方面的專業技術而聞名,此次收購將使GE醫療科技能夠將人工智慧創新帶給更廣泛的臨床醫生和醫療專科。
醫療設備設備市場的主要參與者包括:通用電氣公司、美敦力公司、西門子醫療公司、美光科技公司、英偉達公司、英特爾公司、國際商業機器公司、亞馬遜網路服務公司、皇家飛利浦公司、Enlitic公司、Cloudmedx公司、Oncora Medical、微軟公司、Path AI公司、Aidoc Medicalics、Afunc一天運動公司、AliveAliveAliveTery、Afociiing. AI公司、Babylon Health有限公司、Brainomix有限公司、Butterfly Network公司、佳能醫療系統公司、Cerner公司、Clarapass公司、Comarch SA公司、CureMetrix公司、DeepMind Health公司、Diabetic Retinopathy Detection有限公司、Diacron集團、Diagnostic Robotics公司和EchoPixel公司。
2024年,北美是人工智慧在醫療設備市場中最大的地區。人工智慧在醫療設備市場報告涵蓋以下地區:亞太地區、西歐、東歐、北美、南美、中東和非洲。
這份《人工智慧在醫療設備中的應用市場報告》涵蓋以下國家:澳洲、巴西、中國、法國、德國、印度、印尼、日本、俄羅斯、韓國、英國、美國、加拿大、義大利和西班牙。
醫療設備人工智慧市場由提供醫療設備人工智慧服務的營業單位所獲得的收入構成,例如診斷和治療計劃、遠端監控和機器人手術。市場價值包括服務供應商銷售的相關產品或包含在其服務產品中的相關產品的價值。醫療設備人工智慧市場還包括用於提供醫療設備服務的診斷影像系統、穿戴式裝置、電子健康記錄(EHR)、機器人手術系統和人工智慧監控設備的銷售額。該市場的價值為“出廠價”,即製造商或產品創造者銷售的商品價值,無論銷售對像是其他營業單位(包括下游製造商、批發商、經銷商和零售商)還是直接銷售給最終客戶。該市場中的商品價值還包括產品創造者銷售的任何相關服務。
The utilization of advanced algorithms, machine learning techniques, and other artificial intelligence (AI) technologies in medical devices aims to enhance their performance and capabilities. This integration of AI in medical devices contributes to improved diagnostic accuracy, assistance in surgical procedures, prediction of patient outcomes, and the personalization of treatment plans.
AI in medical devices can be deployed through two main methods, cloud and on-premise. Cloud deployment involves utilizing a remote server network for data storage, processing, and management over the Internet, as opposed to relying on a local server or personal computer. This approach encompasses various technologies such as context awareness, deep learning, machine learning, natural language processing, predictive analytics, among others. These technologies find applications in diverse areas such as patient care, treatment, diagnosis, monitoring, and more. The primary end-users of AI in medical devices include hospitals and healthcare providers, patients, pharmaceutical and biotechnology companies, as well as healthcare payers.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the ensuing trade tensions in spring 2025 are having a significant impact on the information technology sector, especially in hardware manufacturing, data infrastructure, and software deployment. Increased duties on imported semiconductors, circuit boards, and networking equipment have driven up production and operating costs for tech companies, cloud service providers, and data centers. Firms that depend on globally sourced components for laptops, servers, and consumer electronics are grappling with extended lead times and mounting pricing pressures. At the same time, tariffs on specialized software and retaliatory actions by key international markets have disrupted global IT supply chains and dampened foreign demand for U.S.-made technologies. In response, the sector is ramping up investments in domestic chip production, broadening its supplier network, and leveraging AI-powered automation to improve resilience and manage costs more effectively.
The AI in medical devices market research report is one of a series of new reports from The Business Research Company that provides AI in medical devices market statistics, including AI in medical devices industry global market size, regional shares, competitors with AI in medical devices market share, detailed AI in medical devices market segments, market trends and opportunities, and any further data you may need to thrive in the AI in medical devices industry. This AI in medical devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The ai in medical devices market size has grown exponentially in recent years. It will grow from $10.08 billion in 2024 to $12.38 billion in 2025 at a compound annual growth rate (CAGR) of 22.8%. The growth in the historic period can be attributed to early machine learning algorithms, a rise in big data analytics, increased demand for precision medicine, regulatory support and approvals, and early adoption in radiology.
The ai in medical devices market size is expected to see exponential growth in the next few years. It will grow to $34.2 billion in 2029 at a compound annual growth rate (CAGR) of 28.9%. The growth in the forecast period can be attributed to a patient-centric approach, increasing healthcare expenditure, regulatory support and standards, enhanced clinical decision support, and AI in disease prediction and prevention. Major trends in the forecast period include augmented radiology and imaging, AI-powered pathology, genomics and AI integration, predictive analytics in healthcare, and natural language processing (NLP).
The forecast of 28.9% growth over the next five years reflects a modest reduction of 0.6% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US by raising tariffs on AI-enhanced surgical robots, reliant on precision components from Switzerland and Germany, delaying healthcare advancements. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The rising demand for personalized medicine is anticipated to drive the growth of AI in the medical devices market in the future. Personalized medicine is a tailored healthcare approach that considers individual patient characteristics, such as genetics, environment, and lifestyle, to improve treatment effectiveness and outcomes. Several factors contribute to the increasing demand for personalized medicine, including advancements in genomics, greater patient empowerment, and enhanced treatment efficacy. AI processes vast amounts of patient data, encompassing genetic information, medical histories, and lifestyle factors, to develop a comprehensive understanding of individual profiles, which in turn supports the creation of customized treatment plans. For example, the Personalized Medicine Coalition, a non-profit organization based in the U.S., reported in February 2024 that the FDA approved 16 new personalized therapies for patients with rare diseases in 2023, up from six in 2022. Thus, the growing demand for personalized medicine is a key driver of growth for AI in the medical devices market.
The rise in healthcare expenditure is expected to boost the growth of AI in the medical device market in the coming years. Healthcare expenditure encompasses all resources, both financial and non-financial, allocated to the delivery of health services and related activities. This spending is crucial for the adoption and utilization of AI medical devices, as it allows healthcare providers to invest in advanced technologies that enhance patient care and outcomes. For instance, the Canadian Institute for Health Information, a non-profit organization based in Canada, reported in November 2023 that total health expenditure is anticipated to reach $344 billion in 2023, representing a modest increase of 2.8% from the previous year. Consequently, the rise in healthcare expenditure is a significant factor driving the growth of AI in the medical device market.
The AI in medical devices market is experiencing a significant trend driven by technological advancements, with major companies actively adopting new technologies to maintain their market positions. In March 2022, Nvidia Corporation, a US-based computer hardware manufacturing company, introduced the Clara Holoscan MGX, a platform specifically designed for the medical device industry to develop and deploy real-time AI applications at the edge. This innovative platform facilitates the creation of medical devices with advanced AI capabilities, including image and signal processing, natural language processing, and predictive analytics. Furthermore, it incorporates advanced security features and compliance with healthcare industry regulations to ensure the safety and privacy of patient data, allowing real-time processing of medical data and providing valuable insights for clinical decision-making.
Strategic collaborations are a key focus for major companies in the AI in medical devices market, aiming to accelerate the development of AI in the healthcare system and gain a competitive advantage. These collaborations are geared towards leveraging AI to enhance drug discovery, design, and development, as well as improving medical device manufacturing efficiency and risk reduction through machine learning. In March 2023, Medtronic, an Ireland-based medical device company, partnered with NVIDIA Corporation, a US-based software company, to build an AI platform for medical devices. This collaboration involves integrating NVIDIA healthcare and edge AI technology into the Medtronic GI Genius intelligent endoscopy module, the first FDA-approved AI-assisted colonoscopy tool. The strategic partnership aims to expedite the incorporation of AI into the healthcare system and introduce new AI-based solutions for patient care.
In February 2023, GE HealthCare Technologies Inc., a US-based healthcare technology and diagnostics company, completed the acquisition of Caption Health Inc. for $3 billion. This acquisition was driven by the goal of expanding the use cases of Caption AI, developed by Caption Health Inc., beyond cardiology to various medical specialties such as primary care, emergency medicine, and obstetrics. Caption Health Inc. is recognized for its expertise in producing AI medical products, and this acquisition positions GE HealthCare Technologies Inc. to bring AI innovations to a broader range of clinicians and medical specialties.
Major companies operating in the AI in medical devices market include General Electric Company, Medtronic plc., Siemens Healthineers AG, Micron Technology Inc., Nvidia Corporation, Intel Corporation, International Business Machines Corporation, Amazon Web Services, Inc., Koninklijke Philips N.V., Enlitic Inc., Cloudmedx Inc., Oncora Medical Inc., Microsoft Corporation, Path AI Inc., Aidoc Medical Ltd., Accuray Incorporated, AliveCor, Alphabet Inc., Apple Inc., Arterys Inc., Augmedics Inc., Azra AI, Babylon Health Limited, Brainomix Ltd., Butterfly Network Inc., Canon Medical Systems Corporation, Cerner Corporation, Clarapass Inc., Comarch SA, CureMetrix Inc., DeepMind Health, Diabetic Retinopathy Detection Ltd., Diacron Group, Diagnostic Robotics, EchoPixel Inc.
North America was the largest region in the AI in medical devices market in 2024. The regions covered in the ai in medical devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the ai in medical devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The AI in medical devices market consists of revenues earned by entities by providing AI in medical devices such as diagnosis and treatment planning, remote monitoring, and robotic surgery. The market value includes the value of related goods sold by the service provider or included within the service offering. The AI in medical devices market also includes sales of diagnostic imaging systems, wearable devices, electronic health records (EHRs), robotic surgical systems, and AI monitoring devices, which are used in providing AI in medical devices services. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
AI In Medical Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on ai in medical devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for ai in medical devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The ai in medical devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.